Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

McClean PL, Parthsarathy V, Faivre E, Hölscher C.

J Neurosci. 2011 Apr 27;31(17):6587-94. doi: 10.1523/JNEUROSCI.0529-11.2011.

2.
3.

[Glucagon-like peptide-1 (GLP-1) mimetics: a new treatment for Alzheimer's disease?].

García-Casares N, García-Arnés JA, Gómez-Huelgas R, Valdivielso-Felices P, García-Arias C, González-Santos P.

Rev Neurol. 2014 Dec 1;59(11):517-24. Review. Spanish.

4.

Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.

Bak AM, Egefjord L, Gejl M, Steffensen C, Stecher CW, Smidt K, Brock B, Rungby J.

Expert Opin Ther Targets. 2011 Oct;15(10):1153-62. doi: 10.1517/14728222.2011.600691. Epub 2011 Jul 12. Review.

PMID:
21749267
5.

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

Klein WL, Krafft GA, Finch CE.

Trends Neurosci. 2001 Apr;24(4):219-24. Review.

PMID:
11250006
6.

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.

Hölscher C.

J Endocrinol. 2014 Mar 7;221(1):T31-41. doi: 10.1530/JOE-13-0221. Print 2014 Apr. Review.

7.

New animal models of Alzheimer's disease that display insulin desensitization in the brain.

Gao C, Liu Y, Li L, Hölscher C.

Rev Neurosci. 2013;24(6):607-15. doi: 10.1515/revneuro-2013-0034. Review.

PMID:
24259244
8.

Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.

Calsolaro V, Edison P.

CNS Drugs. 2015 Dec;29(12):1023-39. doi: 10.1007/s40263-015-0301-8. Review.

PMID:
26666230
9.

Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.

Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI.

Biochim Biophys Acta. 2013 Apr;1832(4):527-41. doi: 10.1016/j.bbadis.2013.01.008. Epub 2013 Jan 11. Review.

10.

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Talbot K, Wang HY.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. doi: 10.1016/j.jalz.2013.12.007. Review.

11.

Alzheimer's disease and diabetes: new insights and unifying therapies.

Vignini A, Giulietti A, Nanetti L, Raffaelli F, Giusti L, Mazzanti L, Provinciali L.

Curr Diabetes Rev. 2013 May;9(3):218-27. Review.

PMID:
23363296
12.

Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.

Hölscher C.

CNS Drugs. 2012 Oct 1;26(10):871-82. doi: 10.2165/11635890-000000000-00000. Review.

PMID:
22938097
13.

Neurovascular mechanisms of Alzheimer's neurodegeneration.

Zlokovic BV.

Trends Neurosci. 2005 Apr;28(4):202-8. Review.

PMID:
15808355
14.

Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging.

Femminella GD, Edison P.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S55-61. doi: 10.1016/j.jalz.2013.12.012. Review.

PMID:
24529526
15.

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Talbot K.

Neurodegener Dis Manag. 2014;4(1):31-40. doi: 10.2217/nmt.13.73. Review.

16.

Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Candeias EM, Sebastião IC, Cardoso SM, Correia SC, Carvalho CI, Plácido AI, Santos MS, Oliveira CR, Moreira PI, Duarte AI.

World J Diabetes. 2015 Jun 25;6(6):807-27. doi: 10.4239/wjd.v6.i6.807. Review.

17.

[Progress of intervening APP/PS1 bi-transgene dementia model mice by Chinese medicine].

Liang L, Li H, Liu JG.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Sep;33(9):1292-4. Review. Chinese. No abstract available.

PMID:
24273993
18.

Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases.

Hölscher C.

Biochem Soc Trans. 2014 Apr;42(2):593-9. doi: 10.1042/BST20140016. Review.

PMID:
24646283
19.

The role of amyloid-beta in the regulation of memory.

Morley JE, Farr SA.

Biochem Pharmacol. 2014 Apr 15;88(4):479-85. doi: 10.1016/j.bcp.2013.12.018. Epub 2014 Jan 4. Review.

PMID:
24398426
20.

[Protein kinases and Alzheimer's disease].

Wei XL, Zhang YX.

Sheng Li Ke Xue Jin Zhan. 1999 Oct;30(4):359-62. Review. Chinese. No abstract available.

PMID:
12532835

Supplemental Content

Support Center